Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. Read more about Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy. Read more about 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations. Read more about Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations.
Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer. Read more about Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women. Read more about Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial. Read more about Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. Read more about Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. Read more about Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Read more about Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.
